Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Pharma Integrates 2012

28 Nov 2012 - 29 Nov 2012 - London, UK



Bookmark and Share


This is the central question that Pharma Integrates 2012 (PI2012) will tackle. PI2012 is the exclusive retreat for the bio/pharmaceutical procurement and outsourcing elite, bringing together forward thinking and influential leaders from big, emerging and generic pharma alongside leading Contract Research and Manufacturing organisations.

Participants will examine, discuss and debate:

· How to improve R&D Productivity, reduce costs and tap the potential of the emerging economies through improved collaboration

· How to choose the right external partner in an era of consolidation

· When and why should big pharma and generics’ partner

· What are the barriers to open innovation

· And much more…

Attendance will provide participants with a unique opportunity to engage in truly open, interactive and thought provoking discussion, in a prestigious Central London setting away from the day to day business pressures.

For more information on who is attending, presenting and supporting Pharma Integrates 2012, click here. Alternatively please email Christopher Watt or Samuel Thangiah, call +44 (0) 1883 332 607/676




Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!